Human Molecular Genetics, 2001, Vol. 10, No. 9 941-946
© 2001 Oxford University Press
MECP2 is highly mutated in X-linked mental retardation
1INSERM Unité 129-ICGM, CHU Cochin 24 Rue du Faubourg Saint Jacques, 75014 Paris, France, 2Laboratoire de Biochimie et Génétique Moléculaire, CHU Cochin, Paris, France, 3CHU de Tours, Service de Génétique, Hopital Bretonneau, 37044 Tours Cedex, France, 4Centre Universitaire Wallon de Génétique, CUWG CHU Sart Tilman Domaine Universitaire, Liège B-4000, Belgium, 5Max-Plank-Institute for Molecular Genetics, Ihnestrasse 73, Berlin-Dahlem, Germany, 6University Hospital Nijmegen, 417 Department of Human Genetics, 6500 HB Nijmegen, The Netherlands and 7Center for Human Genetics, Clinical Genetics University, UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium
Following the recent discovery that the methyl-CpG binding protein 2 (MECP2) gene located on Xq28 is involved in Rett syndrome (RTT), a wild spectrum of phenotypes, including mental handicap, has been shown to be associated with mutations in MECP2. These findings, with the compelling genetic evidence suggesting the presence in Xq28 of additional genes besides RabGDI1 and FMR2 involved in non-specific X-linked mental retardation (MRX), prompted us to investigate MECP2 in MRX families. Two novel mutations, not found in RTT, were identified. The first mutation, an E137G, was identified in the MRX16 family, and the second, R167W, was identified in a new mental retardation (MR) family shown to be linked to Xq28. In view of these data, we screened MECP2 in a cohort of 185 patients found negative for the expansions across the FRAXA CGG repeat and reported the identification of mutations in four sporadic cases of MR. One of the mutations, A140V, which we found in two patients, has been described previously, whereas the two others, P399L and R453Q, are novel mutations. In addition to the results demonstrating the involvement of MECP2 in MRX, this study shows that the frequency of mutations in MECP2 in the mentally retarded population screened for the fragile X syndrome is comparable to the frequency of the CGG expansions in FMR1. Therefore, implementation of systematic screening of MECP2 in MR patients should result in significant progress in the field of molecular diagnosis and genetic counseling of mental handicap.
+ To whom correspondence should be addressed. Tel: +33 1 44 41 24 10; Fax: +33 1 44 41 24 21; Email: chelly@icgm.cochin.inserm.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Kerr, M. Alvarez-Saavedra, M. A. Saez, A. Saona, and J. I. Young Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice Hum. Mol. Genet., June 15, 2008; 17(12): 1707 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Samaco, J. D. Fryer, J. Ren, S. Fyffe, H.-T. Chao, Y. Sun, J. J. Greer, H. Y. Zoghbi, and J. L. Neul A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome Hum. Mol. Genet., June 15, 2008; 17(12): 1718 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Neul, P. Fang, J. Barrish, J. Lane, E. B. Caeg, E. O. Smith, H. Zoghbi, A. Percy, and D. G. Glaze Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome Neurology, April 15, 2008; 70(16): 1313 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Villard MECP2 mutations in males J. Med. Genet., July 1, 2007; 44(7): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Nan, J. Hou, A. Maclean, J. Nasir, M. J. Lafuente, X. Shu, S. Kriaucionis, and A. Bird Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation PNAS, February 20, 2007; 104(8): 2709 - 2714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Friez, J. R. Jones, K. Clarkson, H. Lubs, D. Abuelo, J.-A. B. Bier, S. Pai, R. Simensen, C. Williams, P. F. Giampietro, et al. Recurrent Infections, Hypotonia, and Mental Retardation Caused by Duplication of MECP2 and Adjacent Region in Xq28 Pediatrics, December 1, 2006; 118(6): e1687 - e1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. McGill, S. F. Bundle, M. B. Yaylaoglu, J. P. Carson, C. Thaller, and H. Y. Zoghbi From the Cover: Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome PNAS, November 28, 2006; 103(48): 18267 - 18272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Moeschler, M. Shevell, and and the Committee on Genetics Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics, June 1, 2006; 117(6): 2304 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M.B. Carvalho, W. Camargos, and S. D.J. Pena Multiplex Protocol Suitable for Screening for MECP2 Mutations in Girls with Mental Retardation. Clin. Chem., March 1, 2006; 52(3): 539 - 540. [Full Text] [PDF] |
||||
![]() |
J. I. Young, E. P. Hong, J. C. Castle, J. Crespo-Barreto, A. B. Bowman, M. F. Rose, D. Kang, R. Richman, J. M. Johnson, S. Berget, et al. Inaugural Article: Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2 PNAS, December 6, 2005; 102(49): 17551 - 17558. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Laumonnier, S Holbert, N Ronce, F Faravelli, S Lenzner, C E Schwartz, J Lespinasse, H Van Esch, D Lacombe, C Goizet, et al. Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate J. Med. Genet., October 1, 2005; 42(10): 780 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erlandson and B. Hagberg MECP2 Abnormality Phenotypes: Clinicopathologic Area With Broad Variability J Child Neurol, September 1, 2005; 20(9): 727 - 732. [Abstract] [PDF] |
||||
![]() |
P. Huppke and J. Gartner Molecular Diagnosis of Rett Syndrome J Child Neurol, September 1, 2005; 20(9): 732 - 736. [Abstract] [PDF] |
||||
![]() |
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, September 1, 2005; 20(9): 736 - 740. [Abstract] [PDF] |
||||
![]() |
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, September 1, 2005; 20(9): 768 - 778. [Abstract] [PDF] |
||||
![]() |
A. Erlandson and B. Hagberg MECP2 Abnormality Phenotypes: Clinicopathologic Area With Broad Variability J Child Neurol, August 1, 2005; 20(8): 727 - 732. [Abstract] [PDF] |
||||
![]() |
P. Huppke and J. Gartner Molecular Diagnosis of Rett Syndrome J Child Neurol, August 1, 2005; 20(8): 732 - 736. [Abstract] [PDF] |
||||
![]() |
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, August 1, 2005; 20(8): 736 - 740. [Abstract] [PDF] |
||||
![]() |
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, August 1, 2005; 20(8): 768 - 778. [Abstract] [PDF] |
||||
![]() |
T Kleefstra, M Smidt, M J G Banning, A R Oudakker, H Van Esch, A P M de Brouwer, W Nillesen, E A Sistermans, B C J Hamel, D de Bruijn, et al. Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome J. Med. Genet., April 1, 2005; 42(4): 299 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Dotti, F. Guideri, M. Acampa, A. Orrico, C. Battisti, and A. Federico Autonomic Dysfunction in Mental Retardation and Spastic Paraparesis With MECP2 Mutation J Child Neurol, December 1, 2004; 19(12): 964 - 966. [Abstract] [PDF] |
||||
![]() |
A. L. Collins, J. M. Levenson, A. P. Vilaythong, R. Richman, D. L. Armstrong, J. L. Noebels, J. David Sweatt, and H. Y. Zoghbi Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum. Mol. Genet., November 1, 2004; 13(21): 2679 - 2689. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Cantagrel, A-M Lossi, S Boulanger, D Depetris, M-G Mattei, J Gecz, C E Schwartz, L Van Maldergem, and L Villard Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males J. Med. Genet., October 1, 2004; 41(10): 736 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Kammoun, N de Roux, O Boespflug-Tanguy, L Vallee, R Seng, M Tardieu, and P Landrieu Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases J. Med. Genet., June 1, 2004; 41(6): e85 - e85. [Full Text] [PDF] |
||||
![]() |
J. L. Neul and H. Y. Zoghbi Rett Syndrome: A Prototypical Neurodevelopmental Disorder Neuroscientist, April 1, 2004; 10(2): 118 - 128. [Abstract] [PDF] |
||||
![]() |
R. C. Samaco, R. P. Nagarajan, D. Braunschweig, and J. M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet., March 15, 2004; 13(6): 629 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Inlow and L. L. Restifo Molecular and Comparative Genetics of Mental Retardation Genetics, February 1, 2004; 166(2): 835 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Zoghbi Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? Science, October 31, 2003; 302(5646): 826 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kriaucionis and A. Bird DNA methylation and Rett syndrome Hum. Mol. Genet., October 15, 2003; 12(90002): R221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Naidu, G. Bibat, L. Kratz, R. I. Kelley, J. Pevsner, E. Hoffman, C. Cuffari, C. Rohde, M. E. Blue, and M. V. Johnston Clinical Variability in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 662 - 668. [Abstract] [PDF] |
||||
![]() |
L Basel-Vanagaite, A Alkelai, R Straussberg, N Magal, D Inbar, M Mahajna, and M Shohat Mapping of a new locus for autosomal recessive non-syndromic mental retardation in the chromosomal region 19p13.12-p13.2: further genetic heterogeneity J. Med. Genet., October 1, 2003; 40(10): 729 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Kudo, Y Nomura, M Segawa, N Fujita, M Nakao, C Schanen, and M Tamura Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain J. Med. Genet., July 1, 2003; 40(7): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Rosa, J. Jankovic, and T. Ashizawa Screening for Mutations in the MECP2 (Rett Syndrome) Gene in Gilles de la Tourette Syndrome Arch Neurol, April 1, 2003; 60(4): 502 - 503. [Full Text] [PDF] |
||||
![]() |
J J Cox, S T Holden, S Dee, J I Burbridge, and F L Raymond Identification of a 650 kb duplication at the X chromosome breakpoint in a patient with 46,X,t(X;8)(q28;q12) and non-syndromic mental retardation J. Med. Genet., March 1, 2003; 40(3): 169 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Turner, F MacDonald, S Warburton, F Latif, and T Webb Developmental delay and the methyl binding genes J. Med. Genet., February 1, 2003; 40(2): e13 - 13. [Full Text] [PDF] |
||||
![]() |
I Longo, S G M Frints, J-P Fryns, I Meloni, C Pescucci, F Ariani, M Borghgraef, M Raynaud, P Marynen, C Schwartz, et al. A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients J. Med. Genet., January 1, 2003; 40(1): 11 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Ravn, J B Nielsen, P Uldall, F J Hansen, and M Schwartz No correlation between phenotype and genotype in boys with a truncating MECP2 mutation J. Med. Genet., January 1, 2003; 40(1): e5 - 5. [Full Text] [PDF] |
||||
![]() |
M. De Rycke, I. Liebaers, and A. Van Steirteghem Epigenetic risks related to assisted reproductive technologies: Risk analysis and epigenetic inheritance Hum. Reprod., October 1, 2002; 17(10): 2487 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Endris, B. Wogatzky, U. Leimer, D. Bartsch, M. Zatyka, F. Latif, E. R. Maher, G. Tariverdian, S. Kirsch, D. Karch, et al. The novel Rho-GTPase activating gene MEGAP/ srGAP3 has a putative role in severe mental retardation PNAS, September 3, 2002; 99(18): 11754 - 11759. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Laccone, B Zoll, P Huppke, F Hanefeld, W Pepinski, and R Trappe MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution J. Med. Genet., August 1, 2002; 39(8): 586 - 588. [Full Text] [PDF] |
||||
![]() |
F E Abidi, E Holinski-Feder, O Rittinger, F Kooy, H A Lubs, R E Stevenson, and C E Schwartz A novel 2 bp deletion in the TM4SF2 gene is associated with MRX58 J. Med. Genet., June 1, 2002; 39(6): 430 - 433. [Full Text] [PDF] |
||||
![]() |
I Meloni, F Vitelli, L Pucci, R B Lowry, R Tonlorenzi, E Rossi, M Ventura, G Rizzoni, C E Kashtan, B Pober, et al. Alport syndrome and mental retardation: clinical and genetic dissection of the contiguous gene deletion syndrome in Xq22.3 (ATS-MR) J. Med. Genet., May 1, 2002; 39(5): 359 - 365. [Full Text] [PDF] |
||||
![]() |
M Fichera, E Borgione, E Avola, S Amata, M Sturnio, C Romano, and A Ragusa A new MRXS locus maps to the X chromosome pericentromeric region: a new syndrome or narrow definition of Sutherland-Haan genetic locus? J. Med. Genet., April 1, 2002; 39(4): 276 - 280. [Full Text] [PDF] |
||||
![]() |
P Nokelainen and J Flint Genetic effects on human cognition: lessons from the study of mental retardation syndromes J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 287 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Kudo, Y Nomura, M Segawa, N Fujita, M Nakao, S Hammer, C Schanen, I Terai, and M Tamura Functional characterisation of MeCP2 mutations found in male patients with X linked mental retardation J. Med. Genet., February 1, 2002; 39(2): 132 - 136. [Full Text] [PDF] |
||||
![]() |
M. T. Dotti, A. Orrico, N. De Stefano, C. Battisti, F. Sicurelli, S. Severi, C. W. Lam, L. Galli, V. Sorrentino, and A. Federico A Rett syndrome MECP2 mutation that causes mental retardation in men Neurology, January 22, 2002; 58(2): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ben Zeev, Y. Yaron, N. C. Schanen, H. Wolf, N. Brandt, N. Ginot, R. Shomrat, and A. Orr-Urtreger Rett Syndrome: Clinical Manifestations in Males With MECP2 Mutations J Child Neurol, January 1, 2002; 17(1): 20 - 24. [Abstract] [PDF] |
||||
![]() |
B. Hendrich and W. Bickmore Human diseases with underlying defects in chromatin structure and modification Hum. Mol. Genet., October 1, 2001; 10(20): 2233 - 2242. [Abstract] [Full Text] [PDF] |
||||












